Swiss Diversified Financial Stock News

SWX:GIVN
SWX:GIVNChemicals

Givaudan (SWX:GIVN) Following Weaker Half Year Results Is Its Valuation Still Compelling

Givaudan (SWX:GIVN) is back in focus after half year 2026 results showed sales of CHF 3,799 million and net income of CHF 475 million, both below the prior year period. See our latest analysis for Givaudan. Givaudan's share price has slipped in recent weeks, with a 7 day share price return of down 5.38% and a 30 day share price return of down 5.16%. However, the 90 day share price return of 14.52% and 3 year total shareholder return of 16.50% point to momentum that has built over a longer...
SWX:NEAG
SWX:NEAGElectric Utilities

Naturenergie Holding (SWX:NEAG) Half Year Earnings Slip Leaves Its Low P/E In Focus

naturenergie holding (SWX:NEAG) released half year 2026 earnings, reporting sales of €661.6 million and net income of €45.5 million, both lower than the prior year period, a development investors are assessing closely. See our latest analysis for naturenergie holding. The earnings setback comes as naturenergie holding’s share price shows mixed momentum, with a 1-month share price return of 3.24% contrasting with a year to date share price decline of 6.18% and a 3-year total shareholder return...
SWX:VONN
SWX:VONNCapital Markets

Is Vontobel Holding (SWX:VONN) Fully Valued On Strong Half Year Earnings And A New CFO?

Vontobel Holding (SWX:VONN) has drawn fresh attention after reporting half year 2026 net income of CHF 216 million, along with plans for seasoned finance executive Antoine Boublil to assume the CFO role from August 2026. See our latest analysis for Vontobel Holding. At a share price of CHF80.2, Vontobel Holding has posted a 30-day share price return of 9.86% and a 90-day gain of 20.24%. Its 1-year total shareholder return of 40.68% points to building momentum around the stronger half year...
SWX:BOSN
SWX:BOSNTrade Distributors

Bossard Holding (SWX:BOSN) Trades At A 47% Premium As Half Year Results Impress

Bossard Holding (SWX:BOSN) has attracted fresh attention after reporting half year 2026 results that show higher sales and net income, along with full year guidance pointing to improved profitability and progress toward medium term financial goals. See our latest analysis for Bossard Holding. The latest full year guidance and half year 2026 earnings have coincided with strong momentum in Bossard Holding’s share price, with a 20.61% 1 month share price return and 51.92% year to date share...
SWX:CLN
SWX:CLNChemicals

Clariant (SWX:CLN) Faces A Fresh Legal Test Following Dow Europe Claim And Fair Value Debate

Clariant (SWX:CLN) has drawn investor attention after Dow Europe filed a new legal claim in the Dortmund court, seeking about €1,100 million in damages related to alleged past competition law infringements. See our latest analysis for Clariant. Since the announcement, Clariant’s share price has been volatile, with a 1-day share price return of 2.13% but a 7-day share price return that declined 3.57%, while the 1-year total shareholder return is down 11.52%. This points to fading longer term...
SWX:SGSN
SWX:SGSNProfessional Services

SGS (SWX:SGSN) Stock Faces Softer H1 EPS Challenging Margin Expansion Narrative

SGS (SWX:SGSN) has posted its H1 2026 results with revenue of CHF3.7b and basic EPS of CHF1.58, while trailing twelve month revenue stands at CHF7.2b with EPS of CHF3.42 alongside year over year earnings growth of 5.6%. Over recent periods the company has seen revenue move from CHF3.4b in H1 2025 to CHF3.5b in H2 2025 and then to CHF3.7b in H1 2026, with half year EPS shifting from CHF1.64 to CHF1.83 and then to CHF1.58, setting up a picture of steady scale and modestly improving net profit...
SWX:VONN
SWX:VONNCapital Markets

Vontobel Holding (SWX:VONN) Stock Tested As Net Profit Margin Jumps To 23.9% And Upside Debated

Vontobel Holding (SWX:VONN) has just posted its H1 2026 scorecard, with investors eyeing the trailing 12-month revenue of CHF1.59b and basic EPS of CHF6.77 as the key markers of current momentum. Over the recent reporting periods, total revenue has moved from CHF694.3m in H2 2024 to CHF741.7m in H2 2025, while basic EPS over those halves shifted from CHF2.44 to CHF2.94. This gives investors a clear read on how the top line and per share earnings are tracking into the latest numbers. With net...
SWX:OFN
SWX:OFNCommercial Services

Orell Füssli (SWX:OFN) Stock Faces Margin Decline That Tests Bullish Growth Narrative

Orell Füssli (SWX:OFN) has opened H1 2026 reporting season with neutral top line and earnings figures on a trailing basis, with TTM revenue at CHF 274.2 million and TTM basic EPS at CHF 8.35. This comes against a backdrop of forecast earnings growth of about 11.9% per year and revenue growth of about 4.8% per year. Over recent periods the company has seen half-year revenue move from CHF 145.41 million with basic EPS of CHF 6.40 in H2 2024, to CHF 120.10 million with EPS of CHF 3.41 in H1...
SWX:STGN
SWX:STGNMachinery

StarragTornos Group (SWX:STGN) Stock Faces Profit Forecast Decline After Return To EPS Of 2.50

StarragTornos Group (SWX:STGN) has reported its H1 2026 numbers with total revenue of CHF 444.4 million on a trailing twelve month basis and basic EPS of CHF 2.50, while the latest half year in 2025 showed revenue of CHF 223.9 million and basic EPS of CHF 2.64. The company has seen revenue move between CHF 239.1 million in H2 2024 and CHF 223.9 million in H2 2025, with basic EPS shifting from CHF 0.97 to CHF 2.64 over the same halves. This sets up a mixed but improving earnings picture. For...
SWX:CALN
SWX:CALNLuxury

Calida Holding (SWX:CALN) Stock Faces 1329% Earnings Swing That Tests Long‑Term Bearish Narratives

CALIDA Holding (SWX:CALN) has reported a cleaner set of numbers for H1 2026, with the latest trailing 12-month figures showing Total Revenue of CHF203.212 million and Basic EPS of CHF0.803, against a backdrop of very large earnings growth from a low base over the past year. Over recent periods, revenue has moved from CHF222.208 million in H1 2025 to CHF215.894 million in H2 2025 and CHF203.212 million on a trailing 12-month basis, while EPS has shifted from a loss of CHF0.074 per share in H1...
SWX:AVOL
SWX:AVOLSpecialty Retail

Avolta (SWX:AVOL) Could Be 31% Undervalued On Aruba Airport Extension

Avolta (SWX:AVOL) stock is in focus after the company secured an eight-year extension to run duty-free stores in Aruba Airport’s redeveloped terminals under the Gateway 2030 program. See our latest analysis for Avolta. The Aruba Airport extension follows a mixed year for Avolta’s stock, with the 1 month share price return down 13.73%, while the 1 year total shareholder return is 11.59% and the 3 year total shareholder return is 13.37%, suggesting gradually building momentum. If this kind of...
SWX:NESN
SWX:NESNFood

Nestlé (SWX:NESN) Stock Faces Margin Squeeze As Net Profitability Undercuts Bullish Growth Narrative

Nestlé (SWX:NESN) has opened H1 2026 with revenue of CHF43.3 billion and basic EPS of CHF1.35, while trailing twelve month revenue sits at CHF88.8 billion with EPS of CHF2.89, giving investors a detailed look at how the business is currently earning its money. Over the last three reported half year periods, revenue has moved from CHF44.4 billion in H1 2025 to CHF45.5 billion in H2 2025 and then CHF43.3 billion in H1 2026, while basic EPS shifted from CHF1.97 to CHF1.54 and then CHF1.35,...
SWX:KNIN
SWX:KNINShipping

Kuehne + Nagel International (SWX:KNIN) Stock Faces Margin Squeeze Despite Q2 EPS Improvement

Kuehne + Nagel International (SWX:KNIN) has reported fresh numbers for Q2 2026, with revenue of CHF 6.6b and basic EPS of CHF 2.26, alongside net income of CHF 268m. The company’s quarterly revenue has moved from CHF 6.1b and EPS of CHF 2.02 in Q2 2025 to CHF 6.6b and EPS of CHF 2.26 in the latest quarter. Trailing 12 month EPS stands at CHF 7.27 on revenue of CHF 24.2b. This sets the backdrop for how investors may interpret today’s figures in light of recent years of weaker earnings and...
SWX:MEDX
SWX:MEDXMedical Equipment

Medmix (SWX:MEDX) Stock Faces Tiny Profit After One Off Loss Tests Bullish Narratives

medmix (SWX:MEDX) has reported H1 2026 results with trailing 12 month revenue of CHF437 million and net income of CHF0.1 million, translating to EPS of CHF0.002. The latest reported half year for 2025 showed revenue of CHF222.6 million and a net loss of CHF0.4 million, or EPS of CHF0.0096. Over the last few reported periods, revenue has moved from CHF242.7 million in H2 2024 to CHF225.4 million in H1 2025 and CHF222.6 million in H2 2025. Over the same timeframe, EPS shifted from a loss of...
SWX:LEON
SWX:LEONCapital Markets

Leonteq (SWX:LEON) Stock Faces Widening Losses Challenging Bullish Earnings Recovery Narrative

Leonteq (SWX:LEON) has kicked off H1 2026 earnings season with a mixed picture, as trailing 12 month figures show total revenue of CHF157.7 million alongside a loss of CHF30.3 million in net income and a basic EPS loss of CHF1.70, while the most recent reported half year in 2025 showed H2 revenue of CHF46.7 million with a net income loss of CHF43.0 million and basic EPS loss of CHF2.42. Over recent halves, total revenue has ranged from CHF104.3 million in H2 2024 to CHF123.7 million in H1...
SWX:ROP
SWX:ROPPharmaceuticals

Roche (SWX:ROG) Stock Margin Expansion To 19.6% Tests Bullish Earnings Narratives

Roche Holding (SWX:ROG) has reported its H1 2026 results with trailing twelve month revenue of CHF 62.96 billion and net income of CHF 12.34 billion, while the latest half year period shows revenue of CHF 31.51 billion, net income of CHF 5.47 billion and basic EPS of CHF 6.87. Over recent half year periods, the company has seen revenue move from CHF 31.64 billion in H2 2024 to CHF 31.85 billion in H1 2025 and CHF 31.51 billion in H2 2025, alongside basic EPS shifting from CHF 2.53 to CHF 9.31...